NU-2058

N/A

Report date: 2023/05/22 10:19:15
NME

Base Information

Drug NameNU-2058
Drug Alias NameNU-2058
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionCyclin-dependent kinase 1 inhibitorsCyclin-dependent kinase 2 inhibitors
TargetsCyclin-dependent kinase 2Cyclin-dependent kinase 1
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesNewcastle University
China Registration ClassN/A

Develop Information

Active CompaniesNewcastle University
Inactive CompaniesN/A
Active IndicationsNeoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A